Biomerica Inc.

NASDAQ:BMRA  
4.36
-0.23 (-5.01%)
Other Pre-Announcement

Biomerica Announces Preliminary Q2 Revenue Increase Of About 238%

Published: 12/16/2021 14:41 GMT
Biomerica Inc. (BMRA) - Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million.
Sees Q2 Revenue About $4.6 Million.
For Q2 Ended November 30, 2021, Company Also Expects to Report an Operating Loss of Between $0.9 Million and $1.3 Million.
Experienced Logistics Constraints and Significantly Higher Shipping Costs Which Had a Material Negative Impact.
Infoods Ibs Clinical Trial on Track for Completion in December.